Letter: Incidence of endometrical carcinoma.

The authors respond to a communication criticizing an earlier article of theirs published in the British Medical Journal, April 3, 1976. They were accused of incorrectly interpreting data on mortality rates for cancer of the corpus uteri, in Wales and England, as evidence that no increase in the inc...

Descrición completa

Detalles Bibliográficos
Main Authors: Doll, R, Kinlen, L, Skegg, D
Formato: Journal article
Idioma:English
Publicado: 1976
_version_ 1826280613476302848
author Doll, R
Kinlen, L
Skegg, D
author_facet Doll, R
Kinlen, L
Skegg, D
author_sort Doll, R
collection OXFORD
description The authors respond to a communication criticizing an earlier article of theirs published in the British Medical Journal, April 3, 1976. They were accused of incorrectly interpreting data on mortality rates for cancer of the corpus uteri, in Wales and England, as evidence that no increase in the incidence of endometrial cancer had occurred. The authors point out that they drew no such conclusion from the mortality rates. Included in the letter are some recent data from Great Britain on the incidence of endometrial cancer and the prescribing of estrogens. among the age groups 40-49, 50-59, 60-69, and 70-79, the % of women who received 1 or more prescriptions were 4.6, 5.9, 1.1, and 1.0, respectively. In view of these low prescription rates, the lack of increase in the incidence of endometrial cancer, up to 1973, and in the mortality from endometrial cancer, up to 1974, in England and Wales is not surprising, nor can this data be used to support or deny an association between the incidence of endometrial cancer and prescribed use of estrogens.
first_indexed 2024-03-07T00:16:19Z
format Journal article
id oxford-uuid:7af6441d-d97a-4005-9d3b-a845b4aa9d1f
institution University of Oxford
language English
last_indexed 2024-03-07T00:16:19Z
publishDate 1976
record_format dspace
spelling oxford-uuid:7af6441d-d97a-4005-9d3b-a845b4aa9d1f2022-03-26T20:47:27ZLetter: Incidence of endometrical carcinoma.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7af6441d-d97a-4005-9d3b-a845b4aa9d1fEnglishSymplectic Elements at Oxford1976Doll, RKinlen, LSkegg, DThe authors respond to a communication criticizing an earlier article of theirs published in the British Medical Journal, April 3, 1976. They were accused of incorrectly interpreting data on mortality rates for cancer of the corpus uteri, in Wales and England, as evidence that no increase in the incidence of endometrial cancer had occurred. The authors point out that they drew no such conclusion from the mortality rates. Included in the letter are some recent data from Great Britain on the incidence of endometrial cancer and the prescribing of estrogens. among the age groups 40-49, 50-59, 60-69, and 70-79, the % of women who received 1 or more prescriptions were 4.6, 5.9, 1.1, and 1.0, respectively. In view of these low prescription rates, the lack of increase in the incidence of endometrial cancer, up to 1973, and in the mortality from endometrial cancer, up to 1974, in England and Wales is not surprising, nor can this data be used to support or deny an association between the incidence of endometrial cancer and prescribed use of estrogens.
spellingShingle Doll, R
Kinlen, L
Skegg, D
Letter: Incidence of endometrical carcinoma.
title Letter: Incidence of endometrical carcinoma.
title_full Letter: Incidence of endometrical carcinoma.
title_fullStr Letter: Incidence of endometrical carcinoma.
title_full_unstemmed Letter: Incidence of endometrical carcinoma.
title_short Letter: Incidence of endometrical carcinoma.
title_sort letter incidence of endometrical carcinoma
work_keys_str_mv AT dollr letterincidenceofendometricalcarcinoma
AT kinlenl letterincidenceofendometricalcarcinoma
AT skeggd letterincidenceofendometricalcarcinoma